Current management of non-Hodgkin malignant lymphoma of the head and neck.
Older nomenclature for non-Hodgkin malignant lymphoma has undergone revision to more accurate terminology based on cytology and histological pattern. Presentation of non-Hodgkin malignant lymphoma above the supraclavicular fossa demands through investigation to rule out occult disease in bone marrow and the intra-abdominal space. This is accomplished by appropriate clinical evaluation including lymphangiogram and exploratory laparotomy. However, the value of exploratory laparotomy for staging on increased survival rates in non-Hodgkin malignant lymphoma of the head and neck has not been established.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007813:Laparotomy; D008198:Lymph Nodes / Q000473:pathology; D008220:Lymphography; D008223:Lymphoma / Q000473:pathology / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000473:pathology; D009303:Nasopharyngeal Neoplasms / Q000473:pathology; D010307:Parotid Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D009626:Terminology as Topic; D014067:Tonsillar Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy
D000970:Antineoplastic Agents